Microsensor Labs connects healthcare and technology to improve lives.

Since 2016, we have not only brought together expertise in medicine, engineering, and computer science, but also collaborated with top research institutes and industry partners all around the country. Together, we develop novel sensor technologies that will address critical, unmet needs in healthcare.
National Institutes of Health Logo
National Science Foundation Logo
United States of America Department of Defense Logo
US Department of Defense Congressionally Directed Medical Research Programs Logo
National Heart, Lung, and Blood Institute Logo
National Institute of Nursing Research Logo
National Institute of General Medical Sciences Logo
National Institute on Aging Logo
National Cancer Institute Logo
University of Louisville Hospital Logo
University of Illinois at Chicago Logo
The University of Chicago Logo
University of Southern California Logo
Argonne National Laboratory Logo
City of Hope Logo
Matter Logo
The University of Chicago Polsky Center for Entrepreneurship and Innovation Logo
Enterpriseworks Chicago Logo



Hand-Hygiene Compliance & Risk Analysis Platform

Healthcare-Associated Infections (HAIs) are the most common type of complication for patients who are hospitalized. According to the Center for Disease Control and Prevention, in 2011 there were an estimated 721,800 HAIs in U.S. acute care hospitals that led to about 75,000 deaths and more than $20 billion in healthcare costs. It is well documented that hand hygiene is one of the most effective measures to reduce the transmission of healthcare-associated pathogens and the incidence of healthcare associated infections.

Our sensor-based platform, Sanibit, helps improve hand hygiene compliance, create a safer environment and reduce infection risks.


Every year more than $250 billion was spent on cancer in the United States. In general, more than 90% of cancer-related deaths are related to metastasis. Metastatic precursors in the bloodstream can potentially be pivotal in early cancer detection, personalized medicine and minimal residual disease monitoring. Compared to fresh tissue biopsy, “liquid biopsy” of bio-markers in blood samples is much more accessible and affordable, and is much less invasive.

MagiCyte, our highly sensitive biosensor platform, helps expedite the cutting-edge research in precision medicine.

Coming Soon →

Contact Us

© 2016–2020 Microsensor Labs, LLC